Karyopharm Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KARYOPHARM THERAPS, and what generic alternatives to KARYOPHARM THERAPS drugs are available?
KARYOPHARM THERAPS has one approved drug.
There are ten US patents protecting KARYOPHARM THERAPS drugs.
There are one hundred and sixteen patent family members on KARYOPHARM THERAPS drugs in thirty-eight countries and fifteen supplementary protection certificates in thirteen countries.
Summary for Karyopharm Theraps
International Patents: | 116 |
US Patents: | 10 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Karyopharm Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | No | 11,746,102 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-002 | Apr 15, 2021 | RX | Yes | No | 9,079,865 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Karyopharm Theraps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20210083380 | ⤷ Try a Trial |
New Zealand | 719623 | ⤷ Try a Trial |
Chile | 2014000224 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Karyopharm Theraps Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2736887 | 21C1042 | France | ⤷ Try a Trial | PRODUCT NAME: SELINEXOR OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; NAT. REGISTRATION NO/DATE: EU/1/21/1537 20210329; FIRST REGISTRATION: FR - EU/1/21/1537 20210329 |
2736887 | 2021C/532 | Belgium | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGE OF OWNER(S) NAME |
2736887 | PA2021007,C2736887 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: SELINEKSORAS; REGISTRATION NO/DATE: EU/1/21/1537 20210326 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.